This inventor holds 3 USPTO granted patents. Top assignees: Japan Energy Corporation, Nippon Mining Co., Ltd.. Active years: 1996-1999.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Toda, JP (1996)
- Saitama, JP (1999)
Company Filing History:
Years Active: 1996-1999
Title: Hitoshi Matsuda: Innovator in Anticoagulant Research
Introduction
Hitoshi Matsuda is a prominent inventor based in Toda, Japan. He has made significant contributions to the field of anticoagulant research, holding a total of 3 patents. His work focuses on the development of hirudin analogs, which have therapeutic potential in preventing blood clots.
Latest Patents
Matsuda's latest patents include innovative methods for manufacturing hirudin analogs and anticoagulant compositions. One of his notable inventions discloses hirudin analogs that substitute specific sequences of naturally-occurring hirudins to enhance stability and anti-thrombin activity. These analogs are designed to suppress the formation of unwanted forms, yielding compounds with high therapeutic potential. Additionally, he has developed a chimeric HV1/HV3 hirudin analog that exhibits superior anti-thrombin activity while minimizing bleeding risks. His patents also encompass methods for producing these compounds using recombinant microorganisms.
Career Highlights
Throughout his career, Matsuda has worked with notable companies such as Japan Energy Corporation and Nippon Mining Co., Ltd. His experience in these organizations has contributed to his expertise in the field of biochemistry and pharmaceutical development.
Collaborations
Matsuda has collaborated with esteemed colleagues, including Satoru Misawa and Yoshifumi Inoue. These partnerships have furthered his research and innovation in the development of anticoagulant therapies.
Conclusion
Hitoshi Matsuda's contributions to the field of anticoagulant research through his innovative patents and collaborations highlight his role as a key inventor in this area. His work continues to have a significant impact on therapeutic advancements in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile